Extended-spectrum beta lactamase by cefotaxime to cefotaxime clavulanate inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD

Preferred Label : Extended-spectrum beta lactamase by cefotaxime to cefotaxime clavulanate inhibitory concentration ratio:PrThr:Pt:Isolate:Ord:Gradient strip ARD;

LOINC status : ACTIVE;

LOINC display name : ESBL by cefotaxime to cefotaxime-clavulanate IC ratio ARD gradient strip Ql (Isol);

LOINC long common name : ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip;

LOINC short name : ESBL cefot cefot-clav IC Islt Ql Grad;

LOINC description : This term is used to report the presence or absence of extended spectrum beta-lactamase (ESBL) enzymes based on inhibitory concentrations of cefotaxime and cefotaxime clavulanate. This term was created for, but is not limited in use to, bioMerieux's ETEST ESBL assay.;

Details

Origin ID

85049-5;

UMLS CUI

C4297167;

Has component
- Beta lactamase [LOINC component]
- Cefotaxime [LOINC component]
- Cefotaxime+Clavulanate [LOINC component]
- Clavulanate [LOINC component]
- Concentration [LOINC component]
- ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [LOINC component]
Has method
- Gradient strip [LOINC method]
- Gradient strip for antimicrobial resistance detection [LOINC method]
Has property
- Presence or Threshold [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Isolate [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients